» Articles » PMID: 16410346

The Inconsistency of "optimal" Cutpoints Obtained Using Two Criteria Based on the Receiver Operating Characteristic Curve

Overview
Journal Am J Epidemiol
Specialty Public Health
Date 2006 Jan 18
PMID 16410346
Citations 661
Authors
Affiliations
Soon will be listed here.
Abstract

The use of biomarkers is of ever-increasing importance in clinical diagnosis of disease. In practice, a cutpoint is required for dichotomizing naturally continuous biomarker levels to distinguish persons at risk of disease from those who are not. Two methods commonly used for establishing the "optimal" cutpoint are the point on the receiver operating characteristic curve closest to (0,1) and the Youden index, J. Both have sound intuitive interpretations--the point closest to perfect differentiation and the point farthest from none, respectively--and are generalizable to weighted sensitivity and specificity. Under the same weighting of sensitivity and specificity, these two methods identify the same cutpoint as "optimal" in certain situations but different cutpoints in others. In this paper, the authors examine situations in which the two criteria agree or disagree and show that J is the only "optimal" cutpoint for given weighting with respect to overall misclassification rates. A data-driven example is used to clarify and demonstrate the magnitude of the differences. The authors also demonstrate a slight alteration in the (0,1) criterion that retains its intuitive meaning while resulting in consistent agreement with J. In conclusion, the authors urge that great care be taken when establishing a biomarker cutpoint for clinical use.

Citing Articles

Joint examination of reflexive vertical saccades and small involuntary fixational saccades improves the classification of patients with progressive supranuclear palsy (PSP): a ROC study.

Becker W, Vintonyak O, Kassubek J Exp Brain Res. 2025; 243(4):90.

PMID: 40080162 PMC: 11906540. DOI: 10.1007/s00221-025-07031-w.


Using the K-Means Node Clustering Method and ROC Curve Analysis to Define Cut-Off Scores for the Caregiving System Scale.

Colledani D, Mikulincer M, Shaver P, Meneghini A Int J Psychol. 2025; 60(2):e70038.

PMID: 40059112 PMC: 11891118. DOI: 10.1002/ijop.70038.


Society for Immunotherapy of Cancer (SITC) consensus statement on essential biomarkers for immunotherapy clinical protocols.

Cottrell T, Lotze M, Ali A, Bifulco C, Capitini C, Chow L J Immunother Cancer. 2025; 13(3).

PMID: 40054999 PMC: 11891540. DOI: 10.1136/jitc-2024-010928.


Is the social withdrawal subscale a valid instrument to assess social withdrawal among colorectal cancer survivors with permanent stomas? A validation study.

Li G, He X, Yao Q, Dong X BMC Psychiatry. 2025; 25(1):202.

PMID: 40045225 PMC: 11881444. DOI: 10.1186/s12888-025-06641-6.


Use of Saliva Analytes as a Predictive Model to Detect Diseases in the Pig: A Pilot Study.

Llamas-Amor E, Ortin-Bustillo A, Lopez-Martinez M, Munoz-Prieto A, Manzanilla E, Arense J Metabolites. 2025; 15(2).

PMID: 39997755 PMC: 11857661. DOI: 10.3390/metabo15020130.


References
1.
Greiner M, Pfeiffer D, Smith R . Principles and practical application of the receiver-operating characteristic analysis for diagnostic tests. Prev Vet Med. 2000; 45(1-2):23-41. DOI: 10.1016/s0167-5877(00)00115-x. View

2.
Schisterman E, Faraggi D, Browne R, Freudenheim J, Dorn J, Muti P . TBARS and cardiovascular disease in a population-based sample. J Cardiovasc Risk. 2001; 8(4):219-25. DOI: 10.1177/174182670100800406. View

3.
Sharir T, Berman D, Waechter P, Areeda J, Kavanagh P, Gerlach J . Quantitative analysis of regional motion and thickening by gated myocardial perfusion SPECT: normal heterogeneity and criteria for abnormality. J Nucl Med. 2001; 42(11):1630-8. View

4.
Levine R, Maynard S, Qian C, Lim K, England L, Yu K . Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med. 2004; 350(7):672-83. DOI: 10.1056/NEJMoa031884. View

5.
Chen R, Rabinovitch P, Crispin D, Emond M, Koprowicz K, Bronner M . DNA fingerprinting abnormalities can distinguish ulcerative colitis patients with dysplasia and cancer from those who are dysplasia/cancer-free. Am J Pathol. 2003; 162(2):665-72. PMC: 1851159. DOI: 10.1016/S0002-9440(10)63860-6. View